Anteris Technologies Global (AVR) Liabilities and Shareholders Equity (2024 - 2026)
Anteris Technologies Global (AVR) reported Liabilities and Shareholders Equity of $294.7 million for Q1 2026, up 401.3% year-over-year from $58.8 million in Q1 2025, and up 1181.57% quarter-over-quarter from $23.0 million in Q4 2025.
Anteris Technologies Global (AVR) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $294.7 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $294.7 million, up 401.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $376.7 million (up 170.03% YoY), and the FY2025 annual result was $23.0 million, down 71.5% from the prior year.
- Liabilities and Shareholders Equity improved to $294.7 million in Q1 2026 per AVR's latest filing, from $23.0 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $294.7 million in Q1 2026 and troughed at $19.1 million in Q3 2025.
- A 3-year average of $86.0 million and a median of $49.3 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity sank 71.5% in 2025, then surged 401.3% in 2026.
- A 3-year view of Liabilities and Shareholders Equity shows it stood at $80.7 million in 2024, then slumped by 71.5% to $23.0 million in 2025, then soared by 1181.57% to $294.7 million in 2026.
- Business Quant data shows AVR's Liabilities and Shareholders Equity at $294.7 million in Q1 2026, $23.0 million in Q4 2025, and $19.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 | 294.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.72 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | 19.07 Mn |
| Jun 30, 2025 | 39.88 Mn |
| Mar 31, 2025 | 58.79 Mn |
| Dec 31, 2024 | 80.70 Mn |